Publicaciones en las que colabora con Vicente E. Climent-Payá (15)

2010

  1. Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease

    International Journal of Cardiology, Vol. 139, Núm. 1, pp. 95-97

2009

  1. Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation

    International Journal of Cardiology, Vol. 132, Núm. 2, pp. 227-232

  2. Left atrial remodelling in hypertrophic cardiomyopathy: Relation with exercise capacity and biochemical markers of tissue strain and remodelling

    International Journal of Clinical Practice, Vol. 63, Núm. 10, pp. 1465-1471

2008

  1. Variables Associated With Contrast-Enhanced Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy: Clinical Implications

    Journal of Cardiac Failure, Vol. 14, Núm. 5, pp. 414-419

2006

  1. Antiplatelet versus anticoagulant therapies in advanced age: An unfinished task

    International Journal of Cardiology, Vol. 110, Núm. 2, pp. 271-272

  2. Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?

    Journal of Thrombosis and Thrombolysis, Vol. 21, Núm. 2, pp. 163-166

2005

  1. Efecto de dosis máximas de atorvastatina en la inflamación, la trombogénesis y la función fibrinolítica en pacientes con cardiopatía isquémica de alto riesgo

    Revista Espanola de Cardiologia, Vol. 58, Núm. 8, pp. 934-940

2004

  1. Matrix Metalloproteinases in Atrial Fibrillation [2] (multiple letters)

    Journal of the American College of Cardiology

  2. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation

    Heart, Vol. 90, Núm. 10, pp. 1162-1166

2003

  1. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

    Stroke, Vol. 34, Núm. 5, pp. 1181-1186

2002

  1. Annexin V levels in survivors of early myocardial

    Revista Espanola de Cardiologia, Vol. 55, Núm. 12, pp. 1230-1234

  2. Hemolytic anemia secondary to paravalvular regurgitation

    Revista Espanola de Cardiologia, Vol. 55, Núm. 9, pp. 987

  3. Prothrombin fragment F1 + 2 and von Willebrand factor levels and left ventricular systolic function. Peripheral versus intracardiac blood samples [8]

    International Journal of Cardiology

2001

  1. Thrombogenic and endothelial damage markers in patients withischemic systolic impairment

    Revista Espanola de Cardiologia, Vol. 54, Núm. 10, pp. 1155-1160

2000

  1. Anticoagulant therapy modifies fibrinolytic dysfunction in chronic atrial fibrillation

    Haemostasis, Vol. 30, Núm. 4, pp. 219-224